tiprankstipranks
Global Blood Therapeutics (GB:0IVZ)
LSE:0IVZ

Global Blood Therapeutics (0IVZ) Stock Investors

0 Followers
Based on 595,212 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0IVZ
On average, investors allocate 3.87% of their portfolios to GB:0IVZ
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 595,212 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0IVZ

0.4%
Last 7
Days
2.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0IVZ, out of 595,212 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0IVZ Investor Activity

No data currently available
Based on the activity of 11,300 investors who made their portfolios public
The table shows changes in 0IVZ in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0IVZ Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Gilead Sciences
4.02%
-0.64%
-0.90%
82.03B
Healthcare
JD
4.15%
-0.48%
-1.40%
83.69B
Consumer Goods
Baidu
4.78%
-0.42%
-1.17%
44.35B
Technology
Novavax
4.28%
-0.37%
-1.90%
1.46B
Healthcare
Crispr Therapeutics AG
4.10%
-0.58%
-1.81%
5.04B
Healthcare
Bristol Myers
3.99%
-0.30%
-0.02%
152.56B
Healthcare
ServiceNow
3.45%
-0.05%
-1.19%
84.96B
Technology
Diamondback
5.27%
+0.50%
+1.84%
24.79B
Utilities
Workhorse Group
3.33%
-0.67%
-2.03%
455.20M
Consumer Goods
Canopy Growth
3.86%
+0.30%
+1.45%
1.48B
Basic Materials
Based on the activity of 595,212 active portfolios
Open your Smart Portfolio

0IVZ Investor Analysis

GB:0IVZ investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
0.0%
of GB:0IVZ holders
are under 35
Average Segment Performance
Average P/E Ratio12.02
Beta4.79
Dividend Yield4.47%
GB:0IVZ investors between 35–55

Between 35–55

3.0%
Last 30 days
Holdings Change
100.0%
of GB:0IVZ holders
are between 35–55
Average Segment Performance
Average P/E Ratio9.33
Beta1.07
Dividend Yield5.31%
GB:0IVZ investors over 55

Over 55

2.9%
Last 30 days
Holdings Change
0.0%
of GB:0IVZ holders
are over 55
Average Segment Performance
Average P/E Ratio9.37
Beta0.87
Dividend Yield4.78%
Overview of age group and performance of GB:0IVZ stock investors
See who invests in 0IVZ according to age group and performance.

FAQ

How many retail Investors hold GB:0IVZ?
<0.1% of TipRanks' retail investors hold GB:0IVZ in their portfolios.
    What is GB:0IVZ Investor Sentiment?
    GB:0IVZ’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GB:0IVZ in the last 7 days?
      ▼ 0.4% of TipRanks' retail investors changed their holding of GB:0IVZ in the last 7 days.
        What percentage of retail investors changed their holding of GB:0IVZ in the last 30 days?
        ▼ 2.7% of TipRanks' retail investors changed their holding of GB:0IVZ in the last 30 days.
          What is the average age of retail investors who hold GB:0IVZ?
          The average age of GB:0IVZ Holders is between 35–55.
            What other stocks have GB:0IVZ investors also bought?
            GB:0IVZ Investors also bought GILD, JD, BIDU, NVAX, CRSP, BMY, NOW, FANG, WKHS, CGC.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AAgilent
              ALNYAlnylam Pharma
              AVEOAVEO Pharma
              BLRXBioline RX Ltd Sponsored ADR
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis